相关实验视频
Updated: Jan 16, 2026

10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
2.3K
在自身免疫性疾病中使用CAR T细胞疗法:机遇和挑战,对RA有影响
Mohamad Mahdi Hojati Shargh1, Mahmoud Mahmoudi1, Seyed Amir Asef Agah2
1Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Tissue & cell
|September 30, 2025
概括
化学抗原受体 (CAR) T细胞疗法通过向特定细胞,对诸如类风湿性关节炎 (RA) 等自身免疫性疾病呈现有前景. 虽然在其他疾病中有效,但RA带来了独特的挑战,需要进一步研究临床应用.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 类风湿病学 类风湿病学
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在血液癌症中取得了成功,目前正在研究自身免疫性疾病.
- 类风湿性关节炎 (RA) 是一种复杂的自身免疫性疾病,具有独特的治疗挑战.
研究的目的:
- 审查CAR T细胞治疗在自身免疫性疾病中的应用,重点是类风湿性关节炎.
- 分析CAR T细胞治疗RA治疗的潜力和挑战.
主要方法:
- 审查关于CAR T细胞技术及其在自身免疫性疾病中的应用现有文献.
- 对系统性红斑狼 (SLE),系统性硬化症 (SSc) 和类风湿性关节炎 (RA) 的临床前和临床数据的分析.
主要成果:
- 通过消耗致病性B细胞,CAR T细胞疗法在SLE和SSc中诱导了持续的缓解.
- RA 带来了挑战,包括疾病异质性和缺乏普遍目标,需要量身定制的临床前方法.
- 在全基CAR T细胞和安全机制方面的进展对于RA的临床实施至关重要.
结论:
- 卡尔T细胞疗法在治疗自身免疫性疾病方面具有显著的潜力,可以提供无药物缓解.
- 由于其复杂性和现有的治疗方法,类风湿性关节炎需要高度精确的CAR T细胞策略.
- 需要进一步的研究和技术进步,以克服RA特异性障碍,以获得成功的CAR T细胞治疗.
相关概念视频
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Autoimmune Disorders
1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
492
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
492
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493

